US-headquartered biopharmaceutical company Alexion Pharmaceuticals is to invest €100m in a new biologics manufacturing facility in its Athlone operations which will result in the creation of 50 additional jobs.
US-headquartered biopharmaceutical company Alexion Pharmaceuticals is to invest €100m in a new biologics manufacturing facility in its Athlone operations which will result in the creation of 50 additional jobs.